合成路线1
该中间体在本合成路线中的序号:
(IV) The chiral precursor (IV) was obtained by two alternative procedures. Addition of cyclopentylmagnesium bromide (II) to ethyl phenylglyoxylate (I) afforded the racemic hydroxyester (III). Basic hydrolysis of the ethyl ester group of (III) gave the corresponding carboxylic acid, which was resolved using cinchonidine.
【1】
Yamakawa, T.; et al.; Synthesis and structure-activity-relationships of 4-acetamidopiperidines as M3 selective antagonists. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.294. |
【2】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41596 |
ethyl 2-oxo-2-phenylacetate
|
1603-79-8 |
C10H10O3 |
详情 | 详情
|
(II) |
41597 |
chloro(cyclopentyl)magnesium
|
32916-51-1 |
C5H9ClMg |
详情 | 详情
|
(III) |
41598 |
ethyl 2-cyclopentyl-2-hydroxy-2-phenylacetate
|
|
C15H20O3 |
详情 |
详情
|
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) An alternative asymmetric procedure consisted in the LDA-promoted addition of cyclopentenone (VI) to the chiral dioxolanone (V), followed by catalytic hydrogenation to furnish (VII). The dioxolane group of (VII) was then cleaved by basic hydrolysis yielding the target (R)-hydroxyacid (IV).
【1】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(V) |
41599 |
(2S,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one
|
|
C13H16O3 |
详情 |
详情
|
(VI) |
25950 |
2-cyclopenten-1-one
|
930-30-3 |
C5H6O |
详情 | 详情
|
(VII) |
41600 |
(2S,5R)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one
|
|
C18H24O3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XII) The alkylation of 4-(tert-butoxycarbonylamino)piperidine (VIII) with (S)-4- methylhexyl methanesulfonate (IX) provided the tertiary amine (X). Cleavage of the Boc protecting group of (X) gave aminopiperidine (XI), which was finally coupled with the chiral hydroxyacid (IV) by means of carbonyl diimidazole.
【1】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
41601 |
tert-butyl 4-piperidinylcarbamate; 4-tert-Boc-aminopiperidine
|
73874-95-0 |
C10H20N2O2 |
详情 | 详情
|
(IX) |
41602 |
(4S)-4-methylhexyl methanesulfonate
|
|
C8H18O3S |
详情 |
详情
|
(X) |
41603 |
tert-butyl 1-[(4S)-4-methylhexyl]-4-piperidinylcarbamate
|
|
C17H34N2O2 |
详情 |
详情
|
(XI) |
41604 |
1-[(4S)-4-methylhexyl]-4-piperidinylamine; 1-[(4S)-4-methylhexyl]-4-piperidinamine
|
|
C12H26N2 |
详情 |
详情
|
(XII) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(IV) In a related procedure, hydroxyacid (IV) was coupled with 1-Boc-4-aminopiperidine (XII) employing EDC and HOBt to give amide (XIII). Acid cleavage of the Boc group of (XIII) yielded amine (XIV), that was finally alkylated with mesylate (IX).
【1】
Yamakawa, T.; et al.; Synthesis and structure-activity-relationships of 4-acetamidopiperidines as M3 selective antagonists. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.294. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(IX) |
41602 |
(4S)-4-methylhexyl methanesulfonate
|
|
C8H18O3S |
详情 |
详情
|
(XII) |
28414 |
4-Amino-1-N-Boc-piperidine; tert-butyl 4-amino-1-piperidinecarboxylate; N-Boc-4-aminopiperidine
|
87120-72-7 |
C10H20N2O2 |
详情 | 详情
|
(XIII) |
41605 |
tert-butyl 4-[[(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoyl]amino]-1-piperidinecarboxylate
|
|
C23H34N2O4 |
详情 |
详情
|
(XIV) |
41606 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenyl-N-(4-piperidinyl)ethanamide
|
|
C18H26N2O2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) Racemic 2-cyclopentyl-2-hydroxy-2-phenylacetic acid (V) was resolved by recrystallization of its cinchonidine salt from toluene to furnish the (-)-(R)-enantiomer (VI). Coupling with amine (IV) by means of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and 1-hydroxybenzotriazole (HOBt) then gave the target amide.
【1】
Mase, T.; Mitsuya, M.; Tsuchiya, Y.; et al.; J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. Bioorg Med Chem 1999, 7, 11, 2555.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31463 |
1-(4-methyl-3-pentenyl)-4-piperidinamine; 1-(4-methyl-3-pentenyl)-4-piperidinylamine
|
|
C11H22N2 |
详情 |
详情
|
(V) |
31465 |
2-cyclopentyl-2-hydroxy-2-phenylacetic acid; alpha-Cyclopentylmandelic acid
|
427-49-6 |
C13H16O3 |
详情 | 详情
|
(VI) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) The condensation of chiral dioxolane (I) with 2-cyclopentenone (II) by means of lithium diisopropylamide (LDA) in THF, followed by reaction with N-phenyl-trifluoromethanesulfonylimide gives the enol triflate (III), which is reduced with H2 over Pd/C in methanol yielding the chiral dioxolane (IV)(as major isomer (93:7)). The hydrolysis of (IV) with NaOH in methanol affords impure acid (V), which was purified through crystallization of its (-)-cinchonidine salt. Pure (V) is finally condensed with piperidine-4-amine (VI) by means of CDI and DIEA in DMF to afford the target amide.
【1】
Mitsuya, M.; et al.; Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129. Bioorg Med Chem Lett 1999, 9, 14, 2037.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31681 |
(2R,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one
|
|
C13H16O3 |
详情 |
详情
|
(II) |
25950 |
2-cyclopenten-1-one
|
930-30-3 |
C5H6O |
详情 | 详情
|
(III) |
31682 |
(3S)-3-[(2R,4R)-2-(tert-butyl)-5-oxo-4-phenyl-1,3-dioxolan-4-yl]-1-cyclopenten-1-yl trifluoromethanesulfonate
|
|
C19H21F3O6S |
详情 |
详情
|
(IV) |
31683 |
(2R,5R)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one
|
|
C18H24O3 |
详情 |
详情
|
(V) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(VI) |
31463 |
1-(4-methyl-3-pentenyl)-4-piperidinamine; 1-(4-methyl-3-pentenyl)-4-piperidinylamine
|
|
C11H22N2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(IV) The chiral precursor (IV) was obtained by two alternative procedures. Addition of cyclopentylmagnesium bromide (II) to ethyl phenylglyoxylate (I) afforded the racemic hydroxyester (III). Basic hydrolysis of the ethyl ester group of (III) gave the corresponding carboxylic acid, which was resolved using cinchonidine.
【1】
Yamakawa, T.; et al.; Synthesis and structure-activity-relationships of 4-acetamidopiperidines as M3 selective antagonists. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.294. |
【2】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41596 |
ethyl 2-oxo-2-phenylacetate
|
1603-79-8 |
C10H10O3 |
详情 | 详情
|
(II) |
41597 |
chloro(cyclopentyl)magnesium
|
32916-51-1 |
C5H9ClMg |
详情 | 详情
|
(III) |
41598 |
ethyl 2-cyclopentyl-2-hydroxy-2-phenylacetate
|
|
C15H20O3 |
详情 |
详情
|
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) An alternative asymmetric procedure consisted in the LDA-promoted addition of cyclopentenone (VI) to the chiral dioxolanone (V), followed by catalytic hydrogenation to furnish (VII). The dioxolane group of (VII) was then cleaved by basic hydrolysis yielding the target (R)-hydroxyacid (IV).
【1】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(V) |
41599 |
(2S,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one
|
|
C13H16O3 |
详情 |
详情
|
(VI) |
25950 |
2-cyclopenten-1-one
|
930-30-3 |
C5H6O |
详情 | 详情
|
(VII) |
41600 |
(2S,5R)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one
|
|
C18H24O3 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) The alkylation of 4-(tert-butoxycarbonylamino)piperidine (VIII) with 5-bromo-2-methyl-2-pentene (IX) provided the tertiary amine (X). Cleavage of the Boc protecting group of (X) gave aminopiperidine (XI), which was finally coupled with the chiral hydroxyacid (IV) by means of carbonyl diimidazole.
【1】
Tsuchiya, Y.; Nomoto, T.; Ohsawa, H.; Kawakami, K.; Ohwaki, K.; Nishikibe, M. (Banyu Pharmaceutical Co., Ltd.); 1,4-Disubstd. piperidine derivs.. EP 0823423; US 5750540; WO 9633973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(VIII) |
41601 |
tert-butyl 4-piperidinylcarbamate; 4-tert-Boc-aminopiperidine
|
73874-95-0 |
C10H20N2O2 |
详情 | 详情
|
(IX) |
31462 |
5-bromo-2-methyl-2-pentene
|
|
C6H11Br |
详情 |
详情
|
(X) |
41607 |
tert-butyl 1-(4-methyl-3-pentenyl)-4-piperidinylcarbamate
|
|
C16H30N2O2 |
详情 |
详情
|
(XII) |
31463 |
1-(4-methyl-3-pentenyl)-4-piperidinamine; 1-(4-methyl-3-pentenyl)-4-piperidinylamine
|
|
C11H22N2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) In a related procedure, hydroxyacid (IV) was coupled with 1-Boc-4-aminopiperidine (XII) employing EDC and HOBt to give amide (XIII). Acid cleavage of the Boc group of (XIII) yielded amine (XIV), that was finally alkylated with bromide (IX).
【1】
Yamakawa, T.; et al.; Synthesis and structure-activity-relationships of 4-acetamidopiperidines as M3 selective antagonists. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.294. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
31466 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoic acid
|
|
C13H16O3 |
详情 |
详情
|
(IX) |
31462 |
5-bromo-2-methyl-2-pentene
|
|
C6H11Br |
详情 |
详情
|
(XII) |
28414 |
4-Amino-1-N-Boc-piperidine; tert-butyl 4-amino-1-piperidinecarboxylate; N-Boc-4-aminopiperidine
|
87120-72-7 |
C10H20N2O2 |
详情 | 详情
|
(XIII) |
41605 |
tert-butyl 4-[[(2R)-2-cyclopentyl-2-hydroxy-2-phenylethanoyl]amino]-1-piperidinecarboxylate
|
|
C23H34N2O4 |
详情 |
详情
|
(XIV) |
41606 |
(2R)-2-cyclopentyl-2-hydroxy-2-phenyl-N-(4-piperidinyl)ethanamide
|
|
C18H26N2O2 |
详情 |
详情
|